Standard Biotools Inc. · NASDAQ:LAB
Eli Casdin reported a 23.90% stake in Standard Biotools Inc. (Schedule 13D/A)
Event Jun 6, 2026 · Filed Jun 9, 2026
Eli Casdin reported a 23.90% stake in Standard Biotools Inc., 93,845,778 shares, with active intent on Jun 6, 2026. Filed Jun 9, 2026 (Schedule 13D/A).
- Stake
- 23.90%
- Shares
- 93,845,778
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Casdin Capital, LLC | 22.70% | 88,783,856 |
| Casdin Private Growth Equity Fund II, L.P. | 3.60% | 13,939,637 |
| Casdin Private Growth Equity Fund II GP, LLC | 3.60% | 13,939,637 |
| Casdin Partners Master Fund, L.P. | 18.50% | 72,100,000 |
| Casdin Partners GP, LLC | 18.50% | 72,100,000 |
| Eli Casdin | 23.90% | 93,845,778 |
Source
Related
- Standard Biotools Inc.
- Casdin Eli
- Standard Biotools Inc. shareholders
- Schedule 13D/A · Casdin Eli · Nov 28, 2025
- Schedule 13D/A · Casdin Eli · Mar 4, 2025
- Form 4 · Mackay Sean · Aug 24, 2026
- Form 4 · Kim Hanjoon Alex · Aug 24, 2026
- Form 4 · Egholm Michael · Aug 24, 2026
- Schedule 13G · Long Focus Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Mak Capital One LLC · Aug 14, 2026